506 related articles for article (PubMed ID: 30173664)
1. A conceptual model for optimizing vaccine coverage to reduce vector-borne infections in the presence of antibody-dependent enhancement.
Tang B; Huo X; Xiao Y; Ruan S; Wu J
Theor Biol Med Model; 2018 Sep; 15(1):13. PubMed ID: 30173664
[TBL] [Abstract][Full Text] [Related]
2. Current concerns and perspectives on Zika virus co-infection with arboviruses and HIV.
Rothan HA; Bidokhti MRM; Byrareddy SN
J Autoimmun; 2018 May; 89():11-20. PubMed ID: 29352633
[TBL] [Abstract][Full Text] [Related]
3. Implication of sexual transmission of Zika on dengue and Zika outbreaks.
Tang B; Zhou WK; Xiao YN; Wu JH
Math Biosci Eng; 2019 Jun; 16(5):5092-5113. PubMed ID: 31499705
[TBL] [Abstract][Full Text] [Related]
4. Dengue and Zika viruses: lessons learned from the similarities between these Aedes mosquito-vectored arboviruses.
Suwanmanee S; Luplertlop N
J Microbiol; 2017 Feb; 55(2):81-89. PubMed ID: 28120186
[TBL] [Abstract][Full Text] [Related]
5. Cross-Protection Against Four Serotypes of Dengue Virus in Mice Conferred by a Zika DNA Vaccine.
Wang R; Gao N; Li Y; Fan D; Zhen Z; Feng K; Chen H; An J
Front Cell Infect Microbiol; 2019; 9():147. PubMed ID: 31139577
[TBL] [Abstract][Full Text] [Related]
6. Dengue Antibody and Zika: Friend or Foe?
Durbin AP
Trends Immunol; 2016 Oct; 37(10):635-636. PubMed ID: 27599407
[TBL] [Abstract][Full Text] [Related]
7. Impact of tetravalent dengue vaccination with screening, ADE, and altered infectivity on single-serotype dengue and Zika transmission.
Kribs C; Greenhalgh D
J Math Biol; 2023 Apr; 86(5):85. PubMed ID: 37119296
[TBL] [Abstract][Full Text] [Related]
8. [Dengue, zika, chikungunya and the development of vaccines].
Kantor IN
Medicina (B Aires); 2018; 78(1):23-28. PubMed ID: 29360072
[TBL] [Abstract][Full Text] [Related]
9. The Challenges Imposed by Dengue, Zika, and Chikungunya to Brazil.
Zanotto PMA; Leite LCC
Front Immunol; 2018; 9():1964. PubMed ID: 30210503
[TBL] [Abstract][Full Text] [Related]
10. Optimal control of vaccination in a vector-borne reaction-diffusion model applied to Zika virus.
Miyaoka TY; Lenhart S; Meyer JFCA
J Math Biol; 2019 Aug; 79(3):1077-1104. PubMed ID: 31187254
[TBL] [Abstract][Full Text] [Related]
11. Implication of vaccination against dengue for Zika outbreak.
Tang B; Xiao Y; Wu J
Sci Rep; 2016 Oct; 6():35623. PubMed ID: 27774987
[TBL] [Abstract][Full Text] [Related]
12. The global spread of Zika virus: is public and media concern justified in regions currently unaffected?
Gyawali N; Bradbury RS; Taylor-Robinson AW
Infect Dis Poverty; 2016 Apr; 5():37. PubMed ID: 27093860
[TBL] [Abstract][Full Text] [Related]
13. The Potential Impact of Vaccination on the Dynamics of Dengue Infections.
Knipl D; Moghadas SM
Bull Math Biol; 2015 Dec; 77(12):2212-30. PubMed ID: 26585748
[TBL] [Abstract][Full Text] [Related]
14. An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.
Urakami A; Ngwe Tun MM; Moi ML; Sakurai A; Ishikawa M; Kuno S; Ueno R; Morita K; Akahata W
J Virol; 2017 Dec; 91(23):. PubMed ID: 28956764
[TBL] [Abstract][Full Text] [Related]
15. Biologic Evidence Required for Zika Disease Enhancement by Dengue Antibodies.
Halstead SB
Emerg Infect Dis; 2017 Apr; 23(4):569-573. PubMed ID: 28322690
[TBL] [Abstract][Full Text] [Related]
16. In-depth molecular analysis of a small cohort of human and Aedes mosquito (adults and larvae) samples from Kolkata revealed absence of Zika but high prevalence of dengue virus.
Sukla S; Ghosh A; Saha R; De A; Adhya S; Biswas S
J Med Microbiol; 2018 Aug; 67(8):1109-1119. PubMed ID: 29897327
[TBL] [Abstract][Full Text] [Related]
17. Zika Virus Replication in a Mast Cell Model is Augmented by Dengue Virus Antibody-Dependent Enhancement and Features a Selective Immune Mediator Secretory Profile.
Coish JM; Crozier RWE; Schieffelin JS; Coorssen JR; Hunter FF; MacNeil AJ
Microbiol Spectr; 2022 Aug; 10(4):e0177222. PubMed ID: 35862953
[TBL] [Abstract][Full Text] [Related]
18. An analysis of community perceptions of mosquito-borne disease control and prevention in Sint Eustatius, Caribbean Netherlands.
Leslie TE; Carson M; Coeverden EV; De Klein K; Braks M; Krumeich A
Glob Health Action; 2017; 10(1):1350394. PubMed ID: 28766466
[TBL] [Abstract][Full Text] [Related]
19. Vaccine development for mosquito-borne viral diseases.
Huang Z; Zhang Y; Li H; Zhu J; Song W; Chen K; Zhang Y; Lou Y
Front Immunol; 2023; 14():1161149. PubMed ID: 37251387
[TBL] [Abstract][Full Text] [Related]
20. Current status, challenges and perspectives in the development of vaccines against yellow fever, dengue, Zika and chikungunya viruses.
Silva JVJ; Lopes TRR; Oliveira-Filho EF; Oliveira RAS; Durães-Carvalho R; Gil LHVG
Acta Trop; 2018 Jun; 182():257-263. PubMed ID: 29551394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
